Lexagene Holdings Inc (fka LXXGQ)

[geodan]

https://lexagene.com/release/2021/miqlab-offers-rapid-plague-detection-for-bioterrorism-threats/ LexaGene’s MiQLab Offers Rapid Plague Detection for Bioterrorism Threats
First-of-its-Kind for Rapidly Detecting Category A Bioterrorism Agents
A brief interview with Dr. Regan regarding LexaGene’s value proposition for pandemic prevention can be viewed HERE.

The 28th International Biothreat and Pathogen Detection Conference is an internationally recognized meeting for experts in the detection and identification of biological threats.
History is filled with numerous instances of naturally occurring outbreaks of biothreat agents that have collectively killed 100’s of millions of people. Plague is arguably the deadliest pathogen of all time.

Plague has caused numerous pandemics in the human history.5 Due to its history as a killer and the potential for plague to still cause a large number of deaths and the difficulty of successful containment, it is classified by the government as Category A Bioterrorism agent.6

In order to demonstrate the MiQLab’s capabilities for biothreat agent detection, LexaGene developed a plague test and completed an analytical evaluation with contrived samples.

Dr. Regan comments, “I’m extremely pleased with the quality of our plague test. In silico analysis showed close to 100% coverage of all plague genomes. Analytical studies showed our test to correlate extremely closely with quantitative culture (R2 > 0.94). Our test is also very sensitive, as we were able to reliably detect levels 1000-fold lower than levels of this bacterium commonly detected in the blood of infected patients.7 Lastly, in an exclusivity study, our test did not cross react with any of the tested phylogenetically related microorganisms. These high-quality test results are a testament to the MiQLab’s capabilities as a surveillance and detection tool when faced with a natural or intentional biothreat.”